# ALX Oncology Holdings Inc: Form 8-K, filed Dec 26, 2023

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: 8-K
- Filed: 2023-12-26
- Accepted by EDGAR: Dec 26, 2023, 21:01 ET
- Period: 2023-12-22
- Accession: 0000950170-23-073016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000095017023073016/alxo-20231222.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000095017023073016/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000095017023073016/alxo-20231222.htm

Filed Dec 26, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-073016. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.